logo
ProjectActive

Lab Stein

Sector: Manufacturing (Industrial) • Location: Costa Rica

Source: International Finance Corporation (IFC)

Founded in Costa Rica, Corporación Stein (“Stein” or the “Company”) is a private, family-owned pharmaceutical group focused on the development, manufacture and commercialization of high-specialty generics. It has operating subsidiaries in six countries and sales in more than 20 countries across LAC, including all countries in Central America. Stein has a manufacturing facility in Costa Rica focuse

Status
Prospective
Sector
Manufacturing (Industrial), Chemical (Industrial), Government, Commercial
Location
Costa Rica
Updated
19 Nov 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Lab Stein

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

5 Q
The project “Lab Stein” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Costa Rica. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

active

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Founded in Costa Rica, Corporación Stein (“Stein” or the “Company”) is a private, family-owned pharmaceutical group focused on the development, manufacture and commercialization of high-specialty generics. It has operating subsidiaries in six countries and sales in more than 20 countries across LAC, including all countries in Central America. Stein has a manufacturing facility in Costa Rica focused on the production of generics. The Company is also engaged in the commercialization of a diversified high-specialty portfolio that includes biosimilars, innovative products, and orphan drugs licensed from global pharmaceutical companies. The Company is focused on the institutional market with over 90% of revenues coming from the public sector.The proposed IFC’s financing aims to support Stein’s growth plan in LAC which includes expansion in the biosimilar, innovative, and orphan drugs segments through new licensing agreements and inorganic growth.

Original sector

other

Budget

Location

Country

Costa Rica

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial), Chemical (Industrial), Government, Commercial

Article published date

2025-08-08

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project